- Home
- Companies
- marshall islands
- antibiotic prescription
Refine by
Antibiotic Prescription Suppliers Serving Marshall Islands
4 companies found
based inSarasota, FLORIDA (USA)
Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and ...
FebriDx is a rapid, all-in-one point-of-care test device that can differentiate a viral from bacterial acute respiratory infection. FebriDx® can be used to help triage patients at the point of care to reduce uncertainty and avoid unnecessary ...
based inSalt Lake City, UTAH (USA)
BioFire Diagnostics sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and ...
The BioFire RP EZ uses a molecular syndromic approach to accurately detect and identify a wide range of pathogens—not just Flu A and Flu B. As a healthcare provider, this means your patients can receive the right treatment the first time, ...
based inBelgrade, SERBIA
Yunycom d.o.o. Belgrade was founded in 1990. as a private company and has been developing their business in the area of import, export and distribution of medical equipment, diagnostic materials and cosmetic products and services. Yunycom’s primary ...
Advanced diagnostics for Urinary tract infection to support treatment decisions; The PA-100 AST System is an automated urine analyser that combines phase contrast microscopy and nanofluidics to make antibiograms available at the point of care. ...
based inLeichhardt, AUSTRALIA
Atomo Diagnostics Limited is a global leader in the user-centered design of innovative, accurate and reliable rapid diagnostics. Atomo has developed the most consumer friendly platform available for rapid at-home testing. Our integrated testing ...
Lumos Diagnostics partnered with Atomo to develop a novel, rapid, point-of-care test that differentiates between viral versus bacterial acute respiratory infection in 10 ...